Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 10/20 | 0.63 |
| ▸ | CTSL | P07711 | 3/20 | 0.60 |
| ▸ | CTSS | P25774 | 3/20 | 0.60 |
| ▸ | CTSK | P43235 | 3/20 | 0.60 |
| ▸ | CTSH | P09668 | 1/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.57 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 1/20 | 0.54 |
| ▸ | GCGR | P47871 | 1/20 | 0.54 |
| ▸ | GIPR | P48546 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655872 | 0.93 | CXCR4 (0.67) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL29913348 | 0.89 | C5AR1 (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30607317 | 0.89 | KEAP1 (0.67) | CXCR4KEAP1C5AR1NPY1RNPY2R | |
| SCHEMBL38663455 | 0.87 | C5AR1 (0.63) | CTSLCTSSCTSKCTSHKEAP1 | |
| SCHEMBL30631666 | 0.87 | CTSL (0.62) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30609006 | 0.87 | CTSL (0.64) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30609002 | 0.87 | CTSL (0.64) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31593288 | 0.87 | C5AR1 (0.63) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30609010 | 0.87 | CTSL (0.60) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30609016 | 0.87 | CTSL (0.60) | CXCR4CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | claimed |
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | CYP24A1, CYP27B1, CYP2R1 | CXCR4 1077/4885CTSL 4268/4885CTSS 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.